KOREA PHARMA Co., Ltd. (KOSDAQ: 032300)
South Korea
· Delayed Price · Currency is KRW 15,300
-420 (-2.67%)
Dec 20, 2024, 1:51 PM KST
KOREA PHARMA Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 19, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 166,763 | 257,943 | 233,403 | 529,520 | 242,129 | - | Upgrade
|
| Market Cap Growth | 2.86% | 10.51% | -55.92% | 118.69% | - | - | Upgrade
|
| Enterprise Value | 150,849 | 248,815 | 222,946 | 528,191 | 235,248 | - | Upgrade
|
| Last Close Price | 15290.00 | 23650.00 | 21352.13 | 48330.28 | 22076.70 | - | Upgrade
|
| PE Ratio | 55.52 | 3079.40 | - | 83.15 | 76.64 | - | Upgrade
|
| Forward PE | - | 82.10 | 82.10 | 112.12 | 39.78 | - | Upgrade
|
| PS Ratio | 2.09 | 3.10 | 2.88 | 6.65 | 3.39 | - | Upgrade
|
| PB Ratio | 2.32 | 3.76 | 3.90 | 9.21 | 5.21 | - | Upgrade
|
| P/TBV Ratio | 2.63 | 3.96 | 4.10 | 9.72 | 5.50 | - | Upgrade
|
| P/FCF Ratio | 35.31 | 78.44 | 40.14 | 114.12 | - | - | Upgrade
|
| P/OCF Ratio | 31.15 | 53.52 | 28.19 | 73.62 | - | - | Upgrade
|
| EV/Sales Ratio | 1.89 | 2.99 | 2.75 | 6.64 | 3.29 | - | Upgrade
|
| EV/EBITDA Ratio | 27.54 | 28.75 | 26.02 | 71.46 | 34.47 | - | Upgrade
|
| EV/EBIT Ratio | 56.15 | 42.60 | 36.03 | 105.34 | 51.10 | - | Upgrade
|
| EV/FCF Ratio | 31.94 | 75.67 | 38.34 | 113.83 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.31 | 0.51 | 0.91 | 0.93 | 0.30 | 0.64 | Upgrade
|
| Debt / EBITDA Ratio | 3.07 | 4.03 | 6.38 | 7.27 | 2.04 | 1.93 | Upgrade
|
| Debt / FCF Ratio | 4.72 | 10.60 | 9.40 | 11.58 | - | 2.75 | Upgrade
|
| Asset Turnover | 0.65 | 0.66 | 0.62 | 0.76 | 0.97 | 1.03 | Upgrade
|
| Inventory Turnover | 2.28 | 2.59 | 2.67 | 2.40 | 2.30 | 2.83 | Upgrade
|
| Quick Ratio | 2.89 | 1.89 | 1.14 | 3.13 | 1.13 | 0.81 | Upgrade
|
| Current Ratio | 4.23 | 2.56 | 1.41 | 3.81 | 1.79 | 1.20 | Upgrade
|
| Return on Equity (ROE) | 4.55% | 0.13% | -1.91% | 12.25% | 8.64% | 22.64% | Upgrade
|
| Return on Assets (ROA) | 2.26% | 2.89% | 2.97% | 2.97% | 3.89% | 6.99% | Upgrade
|
| Return on Capital (ROIC) | 2.66% | 3.35% | 3.43% | 3.65% | 5.53% | 10.65% | Upgrade
|
| Earnings Yield | 1.80% | 0.03% | -0.48% | 1.20% | 1.30% | - | Upgrade
|
| FCF Yield | 2.83% | 1.27% | 2.49% | 0.88% | -1.18% | - | Upgrade
|
| Payout Ratio | 18.18% | 651.04% | - | 8.56% | 13.90% | 7.95% | Upgrade
|
| Buyback Yield / Dilution | -11.10% | -11.22% | 1.22% | -12.80% | -10.95% | -1.93% | Upgrade
|
| Total Shareholder Return | -11.10% | -11.22% | 1.22% | -12.80% | -10.95% | -1.93% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.